David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 2,000 shares at $103.16 ($206K) on 2019-03-01, disclosed to the SEC on 2019-03-01.
Open-market sale of $206k ICPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |
| ICPT | SELL | 2019-01-04 | $46K | — | Filing → |